AI-Driven Orthopedic Surgery Planning: Seeking Software Development Partners for Joint R&D Projects

Salnus is a medtech startup based in İstanbul, specializing in AI-supported surgical planning software and the production of personalized 3D-printed surgical guides for orthopedic procedures. Backed by government-funded R&D programs, Salnus is dedicated to developing innovative, cost-effective solutions that enhance surgical accuracy and outcomes.

We are actively seeking international software development partners to collaborate on joint R&D initiatives. The objective is to accelerate our software development processes, enhance technological innovation, and jointly apply for funding programs such as Horizon Europe, TÜBİTAK, and other EU-backed projects.

Key areas for cooperation include:

• Joint Software Development: Collaborating to advance AI-based surgical planning software, focusing on image processing, algorithm optimization, and user interface development.

• Co-Funding Applications: Partnering for international funding programs to support R&D activities.

• Data Sharing and Research: Engaging in mutual knowledge transfer and technology exchange to enhance AI model training.

• Pilot Testing Collaboration: Conducting joint pilot studies with healthcare institutions for product validation and clinical feedback.

• Market Expansion: Exploring joint strategies for entering new markets and sharing distribution networks.

Why Partner with Salnus?

• Expertise in AI, medical imaging, and 3D printing for orthopedic solutions.

• Access to medical datasets and ongoing scientific research.

• Proven experience in government-funded projects (e.g., TÜBİTAK).

• Competitive cost advantage with locally developed technology.

• Strong commitment to innovation and expanding global partnerships.

We are open to forming long-term, strategic collaborations that foster innovation and accelerate the development of transformative healthcare technologies. If your organization specializes in software development and is looking to engage in impactful, AI-driven medical solutions, we would be keen to connect and explore partnership opportunities.